Pancreatic Cancer Incidence and Mortality by Year, New York State, 1976-2020

Source: New York State Cancer Registry

Year of Diagnosis/Death Incidence Mortality
Males and Females Males Females Males and Females Males Females
Cases Rate per 100,000 Population 95% CI Cases Rate per 100,000 Males 95% CI Cases Rate per 100,000 Females 95% CI Deaths Rate per 100,000 Population 95% CI Deaths Rate per 100,000 Males 95% CI Deaths Rate per 100,000 Females 95% CI
1976 2,105 12.7 12.2-13.3 1,080 15.8 14.8-16.8 1,025 10.6 10.0-11.3 1,979 12.0 11.5-12.6 994 14.7 13.7-15.7 985 10.2 9.6-10.9
1977 2,148 13.1 12.5-13.7 1,093 16.5 15.5-17.5 1,055 10.8 10.2-11.5 2,048 12.5 11.9-13.0 1,038 15.5 14.5-16.5 1,010 10.4 9.8-11.1
1978 2,138 12.8 12.2-13.3 1,078 15.5 14.6-16.5 1,060 10.8 10.1-11.4 2,000 11.9 11.3-12.4 1,008 14.7 13.7-15.6 992 10.0 9.4-10.7
1979 2,221 13.2 12.7-13.8 1,133 16.5 15.5-17.5 1,088 10.9 10.3-11.6 2,109 12.6 12.0-13.1 1,061 15.6 14.6-16.6 1,048 10.5 9.9-11.1
1980 2,197 13.0 12.4-13.5 1,091 15.9 14.9-16.9 1,106 11.0 10.3-11.6 2,016 11.9 11.4-12.5 1,024 15.0 14.1-16.0 992 9.8 9.2-10.5
1981 2,139 12.6 12.1-13.2 1,083 15.7 14.8-16.8 1,056 10.5 9.9-11.2 2,019 11.9 11.4-12.5 1,002 14.6 13.7-15.6 1,017 10.0 9.4-10.7
1982 2,182 12.8 12.2-13.3 1,021 15.1 14.1-16.1 1,161 11.3 10.6-12.0 1,943 11.4 10.9-11.9 947 14.0 13.0-14.9 996 9.7 9.1-10.3
1983 2,113 12.2 11.7-12.8 1,028 14.6 13.7-15.6 1,085 10.5 9.9-11.2 2,047 11.8 11.3-12.3 1,009 14.2 13.3-15.2 1,038 10.1 9.5-10.7
1984 2,181 12.6 12.0-13.1 1,031 15.0 14.1-16.0 1,150 11.0 10.4-11.7 2,016 11.6 11.1-12.2 959 13.9 13.0-14.9 1,057 10.1 9.5-10.8
1985 2,206 12.6 12.1-13.1 1,037 14.5 13.6-15.5 1,169 11.1 10.5-11.8 1,955 11.2 10.7-11.7 930 13.4 12.5-14.3 1,025 9.8 9.2-10.4
1986 2,181 12.5 12.0-13.1 1,025 14.6 13.7-15.5 1,156 11.0 10.4-11.7 2,005 11.4 10.9-12.0 946 13.3 12.4-14.2 1,059 10.0 9.4-10.6
1987 2,201 12.5 12.0-13.0 1,013 14.4 13.5-15.4 1,188 11.1 10.5-11.8 1,988 11.3 10.8-11.8 946 13.5 12.6-14.4 1,042 9.8 9.2-10.4
1988 2,239 12.7 12.2-13.3 1,044 14.8 13.9-15.8 1,195 11.2 10.5-11.8 1,996 11.3 10.8-11.8 960 13.7 12.8-14.7 1,036 9.6 9.0-10.2
1989 2,121 11.9 11.4-12.5 999 14.1 13.2-15.0 1,122 10.5 9.9-11.2 1,961 11.1 10.6-11.6 936 13.3 12.4-14.2 1,025 9.6 9.0-10.2
1990 2,226 12.5 12.0-13.0 1,029 14.4 13.5-15.4 1,197 11.2 10.5-11.8 1,998 11.2 10.7-11.7 915 13.0 12.1-13.9 1,083 10.1 9.5-10.7
1991 2,256 12.6 12.1-13.1 1,059 14.6 13.7-15.5 1,197 11.1 10.4-11.7 1,975 11.0 10.6-11.5 928 12.9 12.1-13.8 1,047 9.7 9.1-10.3
1992 2,243 12.5 12.0-13.0 1,044 14.6 13.7-15.5 1,199 11.0 10.4-11.7 1,966 10.9 10.4-11.4 887 12.5 11.6-13.3 1,079 9.8 9.2-10.4
1993 2,251 12.4 11.9-12.9 1,049 14.2 13.4-15.1 1,202 11.0 10.4-11.6 2,081 11.4 11.0-11.9 980 13.5 12.6-14.4 1,101 10.0 9.4-10.6
1994 2,403 13.2 12.6-13.7 1,132 15.3 14.4-16.2 1,271 11.5 10.9-12.2 2,159 11.8 11.3-12.3 999 13.6 12.8-14.5 1,160 10.4 9.8-11.1
1995 2,279 12.4 11.9-12.9 1,020 13.6 12.8-14.5 1,259 11.4 10.7-12.0 2,072 11.2 10.8-11.7 947 12.6 11.8-13.5 1,125 10.1 9.5-10.7
1996 2,288 12.4 11.9-12.9 1,093 14.6 13.7-15.5 1,195 10.8 10.2-11.5 2,101 11.4 10.9-11.9 965 13.1 12.3-14.0 1,136 10.2 9.6-10.8
1997 2,333 12.5 12.0-13.0 1,095 14.3 13.4-15.1 1,238 11.1 10.5-11.7 2,087 11.2 10.7-11.7 995 13.3 12.5-14.2 1,092 9.7 9.1-10.2
1998 2,439 12.9 12.4-13.5 1,148 14.9 14.0-15.7 1,291 11.5 10.9-12.2 2,093 11.1 10.6-11.6 988 13.0 12.2-13.9 1,105 9.7 9.2-10.3
1999 2,454 12.8 12.3-13.3 1,145 14.5 13.7-15.4 1,309 11.5 10.9-12.1 2,202 11.5 11.0-12.0 1,056 13.5 12.7-14.3 1,146 10.0 9.4-10.6
2000 2,516 12.9 12.4-13.5 1,135 14.2 13.4-15.1 1,381 12.0 11.3-12.6 2,134 11.0 10.5-11.4 967 12.3 11.5-13.1 1,167 10.0 9.4-10.5
2001 2,502 12.7 12.2-13.2 1,112 13.7 12.9-14.5 1,390 11.9 11.3-12.6 2,206 11.2 10.7-11.7 981 12.4 11.6-13.2 1,225 10.4 9.8-11.0
2002 2,533 12.7 12.2-13.2 1,178 14.2 13.4-15.1 1,355 11.5 10.9-12.1 2,182 11.0 10.5-11.4 1,013 12.3 11.6-13.1 1,169 9.8 9.3-10.4
2003 2,611 13.0 12.5-13.5 1,249 15.0 14.2-15.9 1,362 11.4 10.8-12.1 2,168 10.8 10.3-11.2 1,007 12.2 11.4-13.0 1,161 9.6 9.1-10.2
2004 2,600 12.8 12.3-13.3 1,210 14.3 13.5-15.1 1,390 11.6 11.0-12.3 2,247 11.0 10.6-11.5 1,086 12.9 12.2-13.7 1,161 9.6 9.1-10.2
2005 2,609 12.7 12.2-13.2 1,251 14.5 13.7-15.3 1,358 11.3 10.7-11.9 2,249 10.9 10.5-11.4 1,063 12.4 11.7-13.2 1,186 9.7 9.2-10.3
2006 2,732 13.2 12.7-13.7 1,278 14.7 13.9-15.5 1,454 12.0 11.4-12.7 2,246 10.8 10.4-11.3 1,064 12.3 11.6-13.1 1,182 9.7 9.1-10.2
2007 2,806 13.4 12.9-13.9 1,354 15.3 14.5-16.1 1,452 11.8 11.2-12.5 2,289 10.9 10.4-11.3 1,097 12.5 11.8-13.3 1,192 9.7 9.1-10.3
2008 2,927 13.8 13.3-14.3 1,399 15.6 14.8-16.4 1,528 12.4 11.7-13.0 2,392 11.3 10.8-11.7 1,114 12.6 11.8-13.3 1,278 10.2 9.6-10.7
2009 2,950 13.7 13.2-14.2 1,500 16.4 15.5-17.2 1,450 11.6 11.0-12.2 2,427 11.2 10.8-11.7 1,211 13.4 12.6-14.1 1,216 9.6 9.1-10.2
2010 3,016 13.8 13.3-14.4 1,454 15.6 14.8-16.4 1,562 12.5 11.8-13.1 2,429 11.0 10.6-11.5 1,176 12.6 11.9-13.3 1,253 9.7 9.2-10.3
2011 3,114 14.0 13.5-14.5 1,532 16.0 15.2-16.8 1,582 12.4 11.8-13.0 2,474 11.1 10.7-11.6 1,192 12.7 12.0-13.5 1,282 9.9 9.3-10.4
2012 3,147 13.9 13.4-14.4 1,551 16.0 15.2-16.8 1,596 12.4 11.8-13.0 2,568 11.3 10.9-11.8 1,271 13.1 12.4-13.9 1,297 10.0 9.4-10.5
2013 3,227 13.9 13.4-14.4 1,592 15.8 15.0-16.6 1,635 12.3 11.7-13.0 2,542 11.0 10.6-11.4 1,253 12.7 12.0-13.5 1,289 9.6 9.1-10.2
2014 3,320 14.2 13.7-14.7 1,666 16.2 15.4-17.0 1,654 12.5 11.9-13.1 2,597 11.0 10.6-11.4 1,291 12.8 12.1-13.5 1,306 9.6 9.1-10.1
2015 3,358 14.0 13.6-14.5 1,651 15.7 15.0-16.5 1,707 12.6 12.0-13.3 2,521 10.5 10.1-10.9 1,244 12.0 11.3-12.7 1,277 9.2 8.7-9.7
2016 3,464 14.4 13.9-14.9 1,738 16.4 15.6-17.2 1,726 12.7 12.1-13.4 2,675 11.0 10.6-11.4 1,328 12.6 11.9-13.3 1,347 9.7 9.2-10.3
2017 3,651 14.8 14.4-15.3 1,856 17.2 16.4-18.0 1,795 13.0 12.4-13.6 2,727 11.0 10.6-11.4 1,346 12.6 11.9-13.3 1,381 9.7 9.2-10.3
2018 3,616 14.4 14.0-14.9 1,785 16.1 15.4-16.9 1,831 13.0 12.4-13.6 2,688 10.6 10.2-11.0 1,327 12.1 11.4-12.8 1,361 9.4 8.9-9.9
2019 3,702 14.6 14.1-15.1 1,836 16.5 15.7-17.3 1,866 13.0 12.4-13.7 2,772 10.8 10.4-11.2 1,390 12.4 11.7-13.1 1,382 9.5 9.0-10.0
2020 3,583 13.9 13.4-14.4 1,832 15.9 15.2-16.7 1,751 12.2 11.6-12.8 2,721 10.5 10.1-10.9 1,361 12.0 11.4-12.7 1,360 9.3 8.8-9.8

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 20 cases or deaths per year are unstable and should be used with caution.
  • Cancer diagnoses trends in 2020 may have been affected by the coronavirus disease 19 (COVID-19) pandemic.
  • The data in this table are not identical to the data in the corresponding 2016-2020 incidence table. See the rationale in 'Considerations When Comparing Cancer Statistics Over Time'.